Alfavision Overseas (India) Limited (ALFAVIO.BO)
INR 12.51
(-0.56%)
INR 12.51
(-0.56%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 9.28 Million INR | -64.35% |
| 2022 | 25.86 Million INR | -46.58% |
| 2021 | 48.42 Million INR | 23.74% |
| 2020 | 39.13 Million INR | 19.91% |
| 2019 | 32.63 Million INR | 46.55% |
| 2018 | 22.27 Million INR | 25.99% |
| 2017 | 17.67 Million INR | 573.77% |
| 2016 | 2.62 Million INR | 1.94% |
| 2015 | 2.57 Million INR | -8.7% |
| 2014 | 2.81 Million INR | 3.36% |
| 2013 | 2.72 Million INR | 3.62% |
| 2012 | 2.63 Million INR | 277.51% |
| 2011 | 697.23 Thousand INR | -15.49% |
| 2010 | 825 Thousand INR | -30.03% |
| 2009 | 1.17 Million INR | -66.4% |
| 2008 | 3.5 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 865 Thousand INR | 110.73% |
| 2023 Q4 | -8.06 Million INR | -1032.72% |
| 2023 Q3 | -712 Thousand INR | -114.14% |
| 2023 Q2 | 5.03 Million INR | 22.24% |
| 2023 Q1 | 4.11 Million INR | 121.94% |
| 2023 FY | 9.22 Million INR | -64.35% |
| 2022 Q2 | 23.74 Million INR | 57.89% |
| 2022 Q3 | 7.22 Million INR | -69.57% |
| 2022 Q4 | -18.77 Million INR | -359.84% |
| 2022 Q1 | 15.03 Million INR | -50.95% |
| 2022 FY | 25.86 Million INR | -46.58% |
| 2021 Q4 | 30.65 Million INR | 676.69% |
| 2021 Q1 | 3.7 Million INR | -80.26% |
| 2021 Q3 | 3.94 Million INR | -62.41% |
| 2021 Q2 | 10.49 Million INR | 183.14% |
| 2021 FY | 48.42 Million INR | 23.74% |
| 2020 Q2 | 3.38 Million INR | -51.85% |
| 2020 FY | 39.13 Million INR | 19.91% |
| 2020 Q1 | 7.02 Million INR | 14.35% |
| 2020 Q3 | 16.85 Million INR | 398.14% |
| 2020 Q4 | 18.78 Million INR | 11.47% |
| 2019 FY | 32.63 Million INR | 46.55% |
| 2019 Q1 | 6.84 Million INR | -55.14% |
| 2019 Q2 | 7.68 Million INR | 12.18% |
| 2019 Q3 | 10.88 Million INR | 41.66% |
| 2019 Q4 | 6.14 Million INR | -43.54% |
| 2018 Q1 | 2.75 Million INR | 1251.88% |
| 2018 FY | 22.27 Million INR | 25.99% |
| 2018 Q4 | 15.26 Million INR | 1555.2% |
| 2018 Q3 | -1.04 Million INR | -124.73% |
| 2018 Q2 | 4.24 Million INR | 54.09% |
| 2017 Q2 | 1.77 Million INR | 308.03% |
| 2017 FY | 17.67 Million INR | 573.77% |
| 2017 Q1 | 436 Thousand INR | -88.67% |
| 2017 Q3 | -1.12 Million INR | -163.13% |
| 2017 Q4 | -239 Thousand INR | 78.72% |
| 2016 Q4 | 3.84 Million INR | 223.89% |
| 2016 Q3 | -3.1 Million INR | -1511.82% |
| 2016 FY | 2.62 Million INR | 1.94% |
| 2016 Q1 | 1.07 Million INR | 2289.8% |
| 2016 Q2 | 220 Thousand INR | -79.5% |
| 2015 Q4 | -49 Thousand INR | -109.82% |
| 2015 FY | 2.57 Million INR | -8.7% |
| 2015 Q3 | 499 Thousand INR | 12.39% |
| 2015 Q2 | 444 Thousand INR | -68.38% |
| 2015 Q1 | 1.4 Million INR | -24.56% |
| 2014 Q3 | 238 Thousand INR | 17.82% |
| 2014 FY | 2.81 Million INR | 3.36% |
| 2014 Q1 | 1.82 Million INR | 333.26% |
| 2014 Q2 | 202 Thousand INR | -88.95% |
| 2014 Q4 | 1.86 Million INR | 681.92% |
| 2013 Q4 | -783.67 Thousand INR | -360.36% |
| 2013 FY | 2.72 Million INR | 3.62% |
| 2013 Q1 | 678 Thousand INR | -60.95% |
| 2013 Q2 | 1.99 Million INR | 193.81% |
| 2013 Q3 | 301 Thousand INR | -84.89% |
| 2012 Q1 | 380 Thousand INR | 185.71% |
| 2012 Q2 | 174 Thousand INR | -54.21% |
| 2012 FY | 2.63 Million INR | 277.51% |
| 2012 Q3 | 553 Thousand INR | 217.82% |
| 2012 Q4 | 1.73 Million INR | 213.94% |
| 2011 FY | 697.23 Thousand INR | -15.49% |
| 2011 Q3 | 286 Thousand INR | 0.0% |
| 2011 Q4 | 133 Thousand INR | -53.5% |
| 2010 FY | 825 Thousand INR | -30.03% |
| 2010 Q4 | 423 Thousand INR | 0.0% |
| 2009 Q4 | 167 Thousand INR | 0.0% |
| 2009 FY | 1.17 Million INR | -66.4% |
| 2008 FY | 3.5 Million INR | 0.0% |
| 2008 Q4 | 177 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Biocon Limited | 50.83 Billion INR | 99.982% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 99.725% |
| Concord Biotech Limited | 6.26 Billion INR | 99.852% |
| Dishman Carbogen Amcis Limited | -13.9 Million INR | 166.784% |
| FERMENTA BIOTECH LIMITED | 1.06 Billion INR | 99.131% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.27 Million INR | -627.65% |
| Lyka Labs Limited | 29.13 Million INR | 68.133% |
| Panacea Biotec Limited | -309.7 Million INR | 102.997% |
| SAMSRITA LABS LIMITED | -1.49 Million INR | 719.95% |
| Servoteach Industries Limited | -785.00 INR | 1182647.771% |
| SMS Lifesciences India Limited | 359.47 Million INR | 97.418% |
| Supriya Lifescience Limited | 1.57 Billion INR | 99.409% |
| Syngene International Limited | 14.02 Billion INR | 99.934% |
| TAKE Solutions Limited | -213.49 Million INR | 104.348% |
| Titan Biotech Limited | 315.89 Million INR | 97.061% |
| Transgene Biotek Limited | -7.08 Million INR | 230.949% |
| Vanta Bioscience Limited | -31.83 Million INR | 129.157% |